Ensign Group Stock

Ensign Group ROE

The Return on Equity (ROE) of Ensign Group (ENSG) as of Aug 15, 2026 is 15.41 %. In the previous year, Return on Equity (ROE) was 16.22 % — a change of -4.97% (lower).

ROE

15.41 %

YoY

-4.97%

Last updated:

In 2026, Ensign Group's return on equity (ROE) was 15.41 %, a -4.97% increase from the 16.22 % ROE in the previous year.

Access this data via the Eulerpool API

Ensign Group Stock analysis

What does Ensign Group do? The Ensign Group Inc. is an American company that was founded in 1999. Since then, it has become one of the leading providers of healthcare services in the US. The company is listed on the Nasdaq stock exchange and has its headquarters in San Juan Capistrano, California. The company was founded by founder and CEO Christopher Christensen, who had a clear vision of what he wanted to achieve with his own company. He founded Ensign to provide better care for patients and a better working environment for their caregivers. The company started as a small group of healthcare facilities and has since grown steadily. Today, the company operates over 250 facilities in various states across the US. The business model of Ensign is based on providing high-quality healthcare services for patients while building a financially viable company. The company operates various types of facilities, including nursing homes, rehabilitation centers, hospice facilities, and home health care facilities. Ensign offers a wide range of services, including rehabilitation, physical therapy, occupational therapy, speech therapy, and psychological counseling. The company is comprehensive in its approach and provides patients with comprehensive care both medically and in terms of nursing. Ensign has various divisions, including "The Pennant Group," which specializes in home health care services. In this division, nursing services are provided directly at the patient's home. The company also offers specialized hospice care and palliative medicine, focusing on the needs of patients with life-threatening illnesses. In addition, Ensign also offers rehabilitation services that focus on restoring the physical and mental health of patients. Ensign offers a wide range of products and services to meet the needs of its patients. In addition to medical and nursing services, the company also operates facilities that specialize in supporting people with intellectual or physical disabilities. The company also offers care products and materials to facilitate patient care. One of Ensign's most well-known products is the "Ensign Pulser," a medication delivery system designed for the needs of patients with heart conditions. In conclusion, The Ensign Group Inc. is a leading company in the field of healthcare services in the US. The company has a clear vision of providing high-quality care and a better working environment for nursing staff. Ensign's business model is based on providing comprehensive healthcare services in various facilities. Ensign will continue to play an important role in healthcare and help meet the needs of patients. Ensign Group is one of the most popular companies on Eulerpool.

ROE Details

Decoding Ensign Group's Return on Equity (ROE)

Ensign Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ensign Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ensign Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ensign Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ensign Group stock

Return on Equity (ROE) of Ensign Group is 15.41 % in 2026.

Return on Equity (ROE) of Ensign Group changed from 16.22 % to 15.41 %, representing a -4.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Ensign Group since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Ensign Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Ensign Group

All Key Metrics — Ensign Group